Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer (eLEcTRA)

This study has been terminated.
Sponsor:
Collaborator:
Roche - Prof. Dr. Jens Huober et al.
Information provided by:
Novartis
ClinicalTrials.gov Identifier:
NCT00171847
First received: September 13, 2005
Last updated: March 30, 2010
Last verified: March 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)